Microbix Biosystems Inc. provided earnings guidance for the full-year fiscal 2024. The company expects to generate meaningful sales and net earnings growth across full-year fiscal 2024..
Expanded Collaboration to Improve Syndromic Infectious Disease TestingMISSISSAUGA, Ontario and IRVINE, Calif., Dec. 14, 2023 Microbix Biosystems Inc. , a life sciences innovator, manufacturer,.
Meetings with Growth-Oriented Investors, November 17 to 19, 2023MISSISSAUGA, Ontario, Nov. 17, 2023 Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announces.
Microbix Biosystems Inc. , a life sciences innovator, manufacturer, and exporter, announced Thursday the reconfirmation of its agreement with Sequel Pharma, LLC to return Kinlytic urokinase to.
Microbix Biosystems Inc. (TSE:MBX – Get Free Report)’s stock price passed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$0.29 and traded as low as C$0.25. Microbix Biosystems shares last traded at C$0.25, with a volume of 12,000 shares traded. Microbix Biosystems Stock […]